#Neurovascular Devices Market Share

[industryforecastnews]

Neurovascular Devices Market Size To Reach USD 4.53 Billion By 2030

Neurovascular Devices Market Growth & Trends

The global neurovascular devices market size is anticipated to reach USD 4.53 billion by 2030, registering a CAGR of 6.01% from 2023 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.

One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.

The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.

For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.

Request a free sample copy or view report summary: https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

Neurovascular Devices Market Report Highlights

In 2022, cerebral embolization and aneurysm coiling devices dominated the neurovascular devices market with a market share of 34.79%. As the prevalence of cerebral artery stenosis rises, major players are introducing more technologically advanced products

Based on therapeutic application, stroke segment dominated the market in 2022 with a market share of 57.10% due to the increasing prevalence of stroke, globally. The increasing frequency of strokes around the world has resulted in a significant demand for the management of these cases, necessitating the intensive use of neurovascular devices

Among size, 0.021" held a majority market share of 27.26% in the year 2022. This is due to 0.021” size products are preferred over others owing to superior flow rates and embolic compatibility

Among end use, hospitals held a majority market share of 70.97% in the year 2022. Increasing number of patients being admitted to the hospitals due to the surgeries, therapies, and treatments is expected to favor the neurovascular device market. Thus, subsequent increase in number of patients across the globe, launch of technologically advanced products, and favorable reimbursement policies are leading to a growing demand for the hospital treatments

North America led the market with the maximum revenue share of 26.44% in 2022. Rising demand for the minimally invasive surgeries, and increasing government initiative for improving healthcare infrastructures are among the key factors driving the market growth. In addition, technological advancement and innovation of new noninvasive techniques will create lucrative opportunities for the segment

Regional Insights

North America dominated the neurovascular devices market with the share of 26.44% in 2022 owing to the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. in the region. In February 2023, Phenox Inc. stated that their pRESET Thrombectomy Device has been cleared by the FDA for use in the treatment of acute ischemic stroke. The product pRESET, which has been marketed in Europe for more than  a decade, has now been approved for use in the U.S. Furthermore, rising prevalence of neurological disorders, and increasing demand for the minimally invasive surgical procedures are driving the neurovascular devices market growth in this region.

Neurovascular Devices Market Segmentation

Grand View Research has segmented the global neurovascular devices market based on the device, therapeutic application, size, end use, and regions:

Neurovascular Devices Device Outlook (Revenue USD Million; Volume Unit; 2018 - 2030)

Cerebral Embolization and Aneurysm Coiling Devices

Cerebral Angioplasty and Stenting Systems

Neurothrombectomy Devices

Support Devices

Trans Radial Access Devices

Neurovascular Devices Therapeutic Application Outlook (Revenue USD Million; 2018 - 2030)

Stroke

Cerebral Artery

Cerebral Aneurysm

Others

Neurovascular Devices Size (in Inches) Outlook (Revenue USD Million; 2018 - 2030)

0.027"

0.021"

0.071"

0.017"

0.019"

0.013"

0.058"

0.068"

Others

Neurovascular Devices End Use Outlook (Revenue USD Million; 2018 - 2030)

Hospitals

Specialty Clinics

Others

Neurovascular Devices Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East and Africa (MEA)

List of Key Players In Neurovascular Devices Market

Medtronic

Johnson and Johnson Services Inc.

Penumbra, Inc.

Micro port Scientific Corporation

Stryker

Microvention Inc. (Terumo Corporation)

Codman Neuro (Integra Life sciences)

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/neurovascular-devices-market

[market-spy]

Neurovascular Devices Market to Surpass USD 6.04 Billion by 2031, Witnessing 8.5% CAGR Growth | SkyQuest Technology

SkyQuest projects that the Neurovascular Device Market will attain a value of USD 6.04 Billion by 2031, with a CAGR of 8.5% during the forecast period (2024-2031).  The neurovascular devices market is boosted by the growing prevalence of neurological diseases, technological advancement, and rising demand for minimally invasive processes. In recent times, many people are suffering from neurological diseases like brain aneurysm, strokes, and epilepsy, and this is resulting in a significant rise in demand for neurovascular devices. Another disease contributing to the growth of the market is acute ischemic stroke. The popularity of minimally invasive surgeries is also increasing because of the decreases risk and trauma related to these processes. Postoperative pain can be reduced with smaller incisions leading to speedy recovery. These factors are increasing the adoption of these procedures and prompting the advancement of R&D in the field. In recent times, many companies have started investing in R&D to introduce advanced minimally invasive surgical devices. The endovascular coiling utilized for treating intracranial aneurysm is one of such procedures that is widely used by physicians. These types of procedures to treat diseases are increasing the market growth of neurovascular device market.

Download a detailed overview: https://www.skyquestt.com/sample-request/neurovascular-devices-market

Increasing Adoption of Minimally Invasive Surgeries to Reduce Risks will Boost Growth Rate

in the last few years, an inclination towards minimally invasive surgeries have increased among physicians and also patients, increasing its popularity. The primary reason for this is it has very littles risk associated with it and does not create trauma among patients. Small incisions are required to perform the surgeries, which accelerates the recovery timings. These factors have immensely encouraged doctors to implement these surgery techniques. Companies and government institutions are also investing more to improve research and development in this field to increase advancement. The development of technologies like embolic coils, advanced aspiration catheters, revascularization devices for ischemic strokes are the result of R&D. Such innovative devices have encouraged this shift towards advanced neurovascular devices.

Growing Prevalence of Neurovascular Disorder with Changing Lifestyle to Influence Market Growth

The market for neurovascular devices is primarily driven by the increasing cases of neurovascular diseases like strokes or aneurysms. As per NHS England, almost 1 in 12,500 people in England have ruptured brain aneurysm each year. Moreover, brain aneurysm impacts almost 3.0% of the persons of the U.K. Therefore, this rapidly growing patient population for target diseases in the market is mainly responsible for the high consumption of neurovascular devices, resulting in market growth. Another factor positively influencing the neurovascular devices market is the aging of the global population who are extremely vulnerable to chronic diseases and require surgeries. In the past few years, people have witnessed massive lifestyle changes as it has become more fast-paced and unhealthy eating habits have increased. Such lifestyles bring in a lot of risks like diabetes, obesity, and hypertension that can lead to many targeted diseases, increasing neurovascular issues. These factors support the growth of the market.

Increasing Awareness about Neurological Disorders Promotes Neurovascular Devices North America Boosting Market Growth

North America accounts for the dominant market share of neurovascular devices. This can be attributed to factors like increased awareness of neurological disorders, growing geriatric population, and advanced medical care infrastructure. There are also many key players present in the region creating developmental strategies to boost market growth. The market of the Asia-Pacific region is also growing rapidly due to huge population and increasing expenditure on advanced healthcare systems. Rise in disposable is also positively influencing the market as it is encouraging the adoption of neurovascular devices.

Neurovascular Devices Market Insights

Drivers:

Strategic partnerships among key market players to increase the demand for the neurovascular device with advanced products.

Rising geriatric population to create lucrative opportunities for the market.

Emphasis on patient outcome and quality of life is a major factor contributing to the growth.

Better reimbursement policies are accelerating the demand for neurovascular devices.

Restraints:

Strict regulations are an important factor that is decreasing the viability of the market

High expense of neurovascular processes is restraining the market growth

Very less access to advanced healthcare facilities, especially in developing regions can be a challenge

High risk of complications and adverse events can impede the development of the market

Key Players in Neurovascular Market

Acandis GmbH

Asahi Intecc Co. Ltd.

Imperative Care Inc.

Integer Holdings Corporation

Johnson & Johnson

Medtronic plc

MicroPort Scientific Corporation

Penumbra Inc.

Perflow Medical Ltd.

Rapid Medical

Stryker Corporation

Key Questions Answered in the Neurovascular Market

Which are the key players of the neurovascular Market?

What are the critical drivers of the market?

Which region is leading the neurovascular market?

What is neurovascular market growth?

This report provides the following insights:

Analysis of key drivers (Strategic collaboration among companies, rising geriatric population, Emphasis on patient outcome and quality of life, and Better reimbursement), restraints (Integration with existing system and High expense), opportunities (Surging incidences of neurovascular diseases, Increasing technological advancement, High demand for minimally invasive procedures, and Rising awareness), and challenges (Stringent regulations, Restricted access to advanced healthcare, and High risk of complications) influencing the growth of neurovascular devices market

Market Penetration: Comprehensive information on the product offered by the top players in the neurovascular devices market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the neurovascular devices market

Market Development: Comprehensive information on emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

About Us:

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology. 

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.

Contact:

Mr. Jagraj Singh

SkyQuest Technology

1 Apache Way,

Westford,

Massachusetts 01886

USA (+1) 351-333-4748

Email: sales@skyquestt.com

Visit Our Website: https://www.skyquestt.com/

[health-views-updates]

Neurovascular Devices Market Future Outlook: Predictions and Analysis

Neurovascular Devices Market Outlook, Scope & Overview:

Industry reports indicate that the global neurovascular devices market was valued at USD 3.01 billion in 2023 and is projected to reach USD 4.81 billion by 2030, growing at a CAGR of 6.05% over the forecast period 2024-2031.

Technological Advancements to Drive Growth of Global Neurovascular Devices Market

The adoption of advanced neurovascular devices will continue to influence global market revenues. Healthcare providers are increasingly utilizing neurovascular devices due to their effectiveness in treating various cerebrovascular conditions, including aneurysms, arteriovenous malformations, and strokes.

As a product segment, embolization devices currently hold a significant share of the global neurovascular devices market. This segment is anticipated to grow at a year-over-year rate of 6.05% in 2024 over 2023 and reach USD 4.81 billion in revenues by 2030. The increasing prevalence of neurovascular diseases, coupled with advancements in minimally invasive surgical techniques, is expected to drive market growth.

Neurovascular Devices – Market Dynamics

Drivers:

Neurovascular devices are witnessing significant growth in the global market due to their ability to provide effective treatment for cerebrovascular conditions. The demand for minimally invasive procedures, the growing prevalence of neurological disorders, and the increasing geriatric population are key factors driving the adoption of neurovascular devices worldwide. Additionally, technological advancements and the development of novel devices are further propelling market growth.

Restraints:

Despite the growth potential, challenges such as high costs of neurovascular devices, the complexity of procedures, and the need for skilled healthcare professionals are hindering the widespread adoption of these devices. Moreover, stringent regulatory requirements and the risk of complications associated with neurovascular procedures pose additional challenges to market expansion.

Neurovascular Devices – Market Outlook

The proven benefits of neurovascular devices in treating cerebrovascular conditions and improving patient outcomes have contributed to the market's growth. Neurovascular devices are expected to witness increased adoption across major healthcare markets, including North America, Europe, and Asia Pacific, driven by advancements in technology and the increasing focus on improving neurovascular care.

Global Neurovascular Devices Market

The rise in demand for neurovascular devices in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global neurovascular devices market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of neurovascular devices, supported by favorable regulatory frameworks and increasing investments in healthcare infrastructure.

Key Players in the Neurovascular Devices Market

Leading companies in the neurovascular devices market include Medtronic plc, Stryker Corporation, Johnson & Johnson, and Terumo Corporation. These companies are at the forefront of developing and commercializing advanced neurovascular devices for various applications, including aneurysm repair, stroke management, and arteriovenous malformation treatment.

In conclusion, the global neurovascular devices market is poised for substantial growth over the forecast period, driven by technological advancements, increasing prevalence of neurovascular diseases, and the expanding adoption of minimally invasive procedures across diverse healthcare settings.

Other Trending Reports

Neuroprosthetics Industry Trends

Hospital Capacity Management Solutions Industry Trends

3D Printing Medical Devices Industry Trends

Blockchain Technology in Healthcare Industry Trends

[reserchnester-blog]

Neurovascular Devices Market Size, Research & Analysis

The global neurovascular devices market is estimated to garner a revenue of about ~USD 5 billion by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. 

[credenceresearchdotblog]

The Micro Guide Catheters Market is projected to grow from USD 4,315 million in 2024 to USD 7,034.72 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.30%.The global healthcare industry continues to evolve rapidly, driven by advancements in medical technology, growing healthcare expenditure, and the increasing prevalence of chronic diseases. One of the critical components of this industry is the micro guide catheters market, which has seen significant growth over the past few years. These catheters are essential in various minimally invasive procedures, particularly in cardiovascular and neurovascular interventions, where precision and safety are paramount.

Browse the full report at https://www.credenceresearch.com/report/micro-guide-catheters-market

Market Overview

Micro guide catheters are specialized, small-diameter catheters used to navigate complex vascular pathways to deliver therapeutic agents or guide larger catheters to the target site. Their design allows for enhanced maneuverability in intricate anatomical structures, making them indispensable in procedures such as angioplasty, embolization, and stent placement.

As of 2023, the global micro guide catheters market was valued at approximately USD 500 million, with projections indicating a compound annual growth rate (CAGR) of around 7-8% over the next decade. This growth is fueled by several factors, including the rising prevalence of cardiovascular and neurovascular diseases, technological advancements, and an increasing preference for minimally invasive surgeries.

Key Growth Drivers

1. Rising Prevalence of Cardiovascular and Neurovascular Diseases: Cardiovascular diseases (CVDs) remain the leading cause of death globally, accounting for nearly 18 million deaths annually. Similarly, neurovascular diseases, including stroke and aneurysms, pose significant health risks. The growing burden of these diseases has led to a surge in demand for effective treatment options, driving the adoption of micro guide catheters in interventional procedures.

2. Technological Advancements: The development of advanced materials and innovative designs has significantly improved the performance of micro guide catheters. Innovations such as hydrophilic coatings, which reduce friction, and the use of nitinol, a superelastic metal alloy, have enhanced the flexibility, trackability, and safety of these catheters. Additionally, the integration of imaging technologies like intravascular ultrasound (IVUS) with micro guide catheters has enabled more precise navigation and positioning, further boosting their utility in complex procedures.

3. Increasing Preference for Minimally Invasive Surgeries: Minimally invasive surgeries offer numerous advantages over traditional open surgeries, including reduced recovery time, lower risk of complications, and shorter hospital stays. As a result, there has been a growing preference for these procedures among both patients and healthcare providers. Micro guide catheters, which play a crucial role in such surgeries, are thus witnessing increased demand.

4. Aging Population: The global population is aging rapidly, with the number of people aged 65 and older expected to double by 2050. This demographic shift is associated with a higher incidence of chronic conditions such as cardiovascular and neurovascular diseases, leading to a greater need for medical interventions. Consequently, the demand for micro guide catheters is expected to rise in tandem with the aging population.

Regional Market Insights

North America currently dominates the micro guide catheters market, accounting for the largest share due to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and the presence of leading medical device companies. Europe follows closely, driven by the growing adoption of minimally invasive procedures and favorable reimbursement policies.

The Asia-Pacific region is anticipated to witness the fastest growth during the forecast period. This can be attributed to the increasing healthcare expenditure, rising awareness about advanced treatment options, and a rapidly expanding elderly population in countries like China, Japan, and India. Additionally, the improving healthcare infrastructure in these regions is expected to provide significant growth opportunities for market players.

Competitive Landscape

The micro guide catheters market is highly competitive, with several global and regional players vying for market share. Key players include Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Cook Medical, and Asahi Intecc Co., Ltd. These companies are focusing on research and development activities to introduce innovative products and expand their product portfolios.

Strategic collaborations, mergers, and acquisitions are also common strategies adopted by market players to strengthen their market position. For instance, in 2022, Boston Scientific acquired Baylis Medical Company, a move aimed at expanding its electrophysiology and structural heart product portfolio, which includes micro guide catheters.

Future Outlook

The future of the micro guide catheters market looks promising, with continuous advancements in medical technology and the increasing adoption of minimally invasive procedures expected to drive sustained growth. However, challenges such as stringent regulatory requirements and the high cost of advanced micro guide catheters may pose barriers to market expansion.

Key Player Analysis

Covidien AG

Boston Scientific Corporation

Terumo Europe N.V.

Micro Therapeutics Inc.

Volcano Corporation

LuMend Corporation

ASAHI INTECC Company Limited

Lake Region Manufacturing Inc.

Segments:

Based on Product:

Over-the-wire Micro Guide Catheters

Flow-directed Micro Guide Catheters

Based on Application:

Cardiovascular

Neurovascular

Other Applications

Based on End User:

Hospitals/Clinics

Ambulatory Surgical Centers

Based on the Geography:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/micro-guide-catheters-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[futuristicpaintercat]

Neuro-interventional Devices Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Neurovascular and Neurological Disorders

The neuro-interventional devices market comprises devices that include embolic coils, flow diverters, distal access catheters, liquid embolics, coil assist stents, micro-catheters, balloon guiding catheters, neurovascular stents, and stent retrievers. These devices are used for the diagnosis and treatment of neurovascular and neurological disorders including cerebral aneurysm, carotid artery stenosis, arteriovenous malformation, and ischemic stroke. The increasing number of patients suffering from these disorders has boosted the demand for advanced neuro-interventional devices.

The Global neuro-interventional devices market is estimated to be valued at US$ 2.7 Bn in 2024 and is expected to exhibit a CAGR of 5.0% over the forecast period 2024 To 2031. Key Takeaways Key players operating in the neuro-interventional devices are Penumbra, Inc., Stryker Corporation, Medtronic PLC., Johnson and Johnson Services, Inc., Terumo Corporation, Insera Therapeutics Inc., Anaconda Biomed S.L., NeuroVasc Technologies and Perflow Medical Ltd. These players are focusing on new product launches and geographic expansions to strengthen their market position. Some of the key opportunities in the market include growing preference for minimally invasive surgeries and the untapped potential in emerging economies. The increasing healthcare expenditure and growing demand for advanced medical technologies in countries such as China, India, Brazil, and Mexico will support the market growth. The rising medical tourism in Asian and Latin American countries also offers opportunities for manufacturers. These regions offer neuro-interventional surgeries at affordable costs as compared to developed nations in North America and Western Europe. Market Drivers The increasing prevalence of neurovascular and neurological disorders is one of the key drivers of the Neuro-Interventional Devices Market Share. According to estimates, nearly one-fourth of the population is likely to suffer a stroke during their lifetime. The growing number of ischemic strokes owing to changing lifestyle habits will eventually increase the demand for neurological devices. Advanced neuro-interventional devices are more effective and safer as compared to traditional open surgery which involves risks of infection, blood loss, and long recovery time. The advantages offered by minimally invasive endovascular procedures in reducing complications are expected to contribute to the high growth of the neuro-interventional devices market during the forecast period.

PEST Analysis Political: Government policies and regulations play a major role in determining the growth of the neuro-interventional devices market. Regulations on approval, adoption and reimbursement of new devices shape industry developments. Economic: Economic growth, rise in healthcare spending and increasing disposable income have positively impacted market growth over the last few years. However, the current economic slowdown caused by COVID-19 pandemic poses short term challenges. Social: Rising geriatric population and incidence of neurological disorders like stroke, aneurysm, arteriovenous malformation drives demand for neuro-interventional devices. Higher awareness and access to sophisticated treatment methods fuels adoption. Technological: Advancements in design, material and manufacturing improve effectiveness and reduce risks of procedures. Developments in 3D printing, navigation systems and bioabsorbable materials support new product innovations. Continued R&D lead to improved patient care. The North American region currently holds the largest share of the neuro-interventional devices market in terms of value. High healthcare spending, availability of advanced healthcare facilities, and favorable reimbursement policies are key factors supporting market growth in this region. The Asia Pacific region is anticipated to grow at the fastest rate over the forecast period. Rapidly developing healthcare infrastructure, increasing healthcare expenditure, rising incidence of brain disorders and growing demand for minimally invasive surgical techniques are driving the neuro-interventional devices market in Asia Pacific region. Countries like India, China and Japan are expected to provide lucrative opportunities.

Get more insights on Neuro-interventional Devices Market

About Author:

Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163)

[healthcaremarketanalysis]

X-Ray Detectors Market Size, Share, Trends and Revenue Forecast [2029]

The global X-Ray Detectors market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.2 billion by 2029, growing at a CAGR of 5.0% from 2023 to 2029. 

Download an Illustrative overview:

X-Ray Detectors Market: Market Dynamics

Driver: Investment to advance healthcare facilities & digital imaging Technologies.

X-Ray detectors play a crucial role in facilitating the work of healthcare professionals in diagnosing and treating patients. The efficient utilization of cutting-edge equipment, like X-ray detectors, enables the screening of a greater number of patients at reduced expenses and with significant time savings. Increased support, funding, and investments are expected to substantially enhance the accessibility and adoption of these technologies, contributing to the continued growth of the market.

Restraint: High cost of X-ray detectors

The X-ray detector market faces limitations due to the high cost associated with these devices. Beyond being a constraint, this factor poses a challenge for economically disadvantaged and developing nations seeking to embrace new technologies. Insufficient funding in many hospitals further hinders the possibility of acquiring these modern technologies. As countries globally aim to advance and integrate state-of-the-art technologies, manual security checks are becoming obsolete. However, the concern of health hazards arises, particularly in security applications, as these detectors have demonstrated a potential link to cancer, presenting a genuine limitation. Additionally, addressing the shortage of qualified radiologists is another pressing issue that needs attention.

Opportunity: Rising healthcare expenditure across developing countries

Within the X-ray detector market, there are promising opportunities in emerging regions like the Asia-Pacific (APAC) and India. These countries are experiencing substantial growth in medical tourism, fueled by factors such as population expansion, increasing sedentary lifestyles, and the rapid development of medical tourism infrastructure. These elements are driving an uptick in health issues like cardiovascular and neurovascular diseases. Furthermore, these nations boast above-average returns on investments and are recognized for having a skilled labor force. Government initiatives and policies are actively fostering the development and expansion of the medical tourism industries in these countries.

Challenge: Lack of animal awareness in emerging and developing countries

The X-ray detector market faces ongoing challenges from global competitors, with Chinese players holding significant influence. Moreover, the expenditure on animal health in developing nations, such as India, China, and Africa, is notably limited when compared to industrialized countries like North America. Additionally, these growing nations lack a well-established understanding of animal health, prioritizing therapeutic medical treatments over procedures involving X-ray detectors.

By region, North America is expected to be the largest market in the x-ray detectors industry during the forecast period.

North America, comprising the US and Canada, accounted for the largest share of the X-ray detectors market in 2022. The growth of the X-ray detector market in North America is propelled by several factors, including the rising number of target diagnostic and interventional procedures conducted in the region, a high prevalence of diseases, an increasing geriatric population, and the widespread availability of advanced interventional products, including microcatheters.

As of 2022, prominent players in the X-ray detectors market are Varex Imaging Corporation(US), Thales Group ( France), Canon ( Japan), Fujifilm Corporation (Japan), Agfa-Gevaert Group (Belgium) and Teledyne Technologies(US), and among others.

Recent Developments of X-Ray Detectors Industry:

In May 2023, Varex Imaging Corporation launched the XRD 3131N digital X-ray detector to cater to the rising demand for expedited and more extensive inspections within the rapidly evolving Electric Vehicle (EV) battery manufacturing sector. This enhances the company's existing portfolio for the EV battery inspection market.

In July 2022, Canon Inc. launched the CXDI-Elite series of wireless digital radiography (DR2) devices, including the CXDI-720C Wireless sensor unit, to markets outside of Japan. These devices aim to enhance user-friendliness across various imaging scenarios while delivering superior image quality to facilitate more accurate diagnostics.

March 2021, At ECF 2021, the Thales unveiled the Pixium 3040F, featuring enhanced image quality, optimized spatial resolution, increased contrast, and superior sensitivity at lower radiation doses.

Frequently Asked Questions (FAQ):

1) What is the projected market revenue value of the global X-Ray Detectors Market?

The global X-Ray Detectors market boasts a total revenue value of $4.2 billion by 2029.

2) What is the estimated growth rate (CAGR) of the global X-Ray Detectors Market?

The global X-Ray Detectors market has an estimated compound annual growth rate (CAGR) of 5.0% and a revenue size in the region of $3.1 billion in 2023. 

Request Sample Pages:

[navalvessels]

The Neurovascular Thrombectomy Devices market size was $872.5 million in 2023. Factors such as constant revision of protocol and best practice guidelines will drive the market growth at a CAGR of more than 8% from 2023 to 2033.

[health-views-updates]

The Future of the Geographic Atrophy Market: Trends and Challenges

Geographic Atrophy Market Outlook, Scope & Overview:

Industry reports indicate that the geographic atrophy (GA) market is projected to grow at a CAGR of 7.2% over the forecast period 2023-2030.

Technological Advancements to Drive Growth of Global Geographic Atrophy Market

The adoption of advanced diagnostic and therapeutic solutions for geographic atrophy will continue to influence global market revenues. Healthcare providers and pharmaceutical companies are increasingly focusing on innovative treatments and early diagnosis methods to manage and treat geographic atrophy, a progressive and irreversible condition that leads to the degeneration of the retina.

As a treatment segment, emerging therapies currently hold a significant potential share of the global geographic atrophy market. This segment is anticipated to grow at a year-over-year rate of 7.2% over the forecast period, driven by the increasing prevalence of GA and the rising investment in research and development for effective therapies.

Get a Free Sample Report of Vitamins Market: https://www.snsinsider.com/sample-request/2480 

Geographic Atrophy Market Dynamics

Drivers:

The geographic atrophy market is witnessing significant growth due to the rising prevalence of age-related macular degeneration (AMD), of which GA is an advanced form. The growing elderly population, increasing awareness about retinal diseases, and the development of innovative treatment options are key factors driving the adoption of GA therapies worldwide. Additionally, advancements in imaging technologies and diagnostic tools are further propelling market growth by enabling early detection and intervention.

Restraints:

Despite the growth potential, challenges such as the high cost of emerging therapies, limited treatment options, and the complexity of clinical trials for GA are hindering the widespread adoption of geographic atrophy treatments. Moreover, the chronic nature of the disease and the need for long-term management pose additional challenges to market expansion.

Geographic Atrophy Market Outlook

The proven benefits of early diagnosis and innovative treatments in managing geographic atrophy have contributed to the market's growth. The geographic atrophy market is expected to witness increased adoption of advanced therapies across major healthcare markets, including North America, Europe, and Asia Pacific, driven by advancements in medical research and the growing focus on improving patient outcomes.

Global Geographic Atrophy Market

The rise in demand for geographic atrophy treatments in developed and emerging markets is expected to drive market growth over the forecast period. North America currently holds a significant market share in the global geographic atrophy market, with the US being a key contributor to market revenues. Europe and Asia Pacific regions are also experiencing rapid adoption of GA therapies, supported by favorable regulatory frameworks and increasing investments in healthcare infrastructure.

Key Players in the Geographic Atrophy Market

Leading companies in the geographic atrophy market include Apellis Pharmaceuticals, IVERIC bio, Roche, and Alkeus Pharmaceuticals. These companies are at the forefront of developing and commercializing advanced therapies and diagnostic tools for geographic atrophy, aiming to improve patient quality of life and slow disease progression.

In conclusion, the global geographic atrophy market is poised for steady growth over the forecast period, driven by technological advancements, increasing prevalence of retinal diseases, and the expanding adoption of innovative therapies and diagnostic solutions in managing geographic atrophy

Other Trending Reports

Nicotine Replacement Therapy Industry Growth

Dry Age-Related Macular Degeneration Industry Growth

Neurovascular Devices Industry Growth

Artificial Intelligence in Drug Discovery Industry Growth

[blueweave]

Neurovascular Thrombectomy Devices Market size at USD 2.17 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Neurovascular Thrombectomy Devices Market size to expand at a CAGR of 6.88% reaching a value of USD 4.08 billion by 2030. The growing incidence of neurovascular illnesses and the expanding need for efficient treatment options are key drivers of growth for the Global Neurovascular Thrombectomy Devices Market. Furthermore, during the period in analysis, the market is expected to witness lucrative opportunities due to the expansion of research and development activities in the field of interventional neurology.

Opportunity - Rising accessibility to healthcare facilities

The Global Neurovascular Thrombectomy Devices Market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others, based on end user. The hospitals segment holds the largest market share, mainly due to the high number of patients with neovascular diseases approaching hospitals for the diagnosis and treatment of various conditions. The increasing number of hospitals, particularly in emerging economies, such as India and China, owing to healthcare infrastructure growth, is anticipated to drive the hospital segment in the Global Neurovascular Thrombectomy Devices Market during the period in analysis.

Sample Request @ https://www.blueweaveconsulting.com/report/neurovascular-thrombectomy-devices-market/report-sample